- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07566143
Social Cognitive Theory-Based Education for Improving Health Outcomes in Older Adults (SCT-OLD)
Effect of a Social Cognitive Theory-Based Education Program on Self-Efficacy, Healthy Lifestyle Behaviors, and Health Literacy in Older Adults Attending Primary Care Centers: A Randomized Controlled Trial
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
This study is designed as a randomized controlled trial to evaluate the impact of a Social Cognitive Theory-based educational intervention on self-efficacy, healthy lifestyle behaviors, and health literacy among older adults. The study will be conducted in a primary care setting and will include individuals aged 65 years and older who meet the inclusion criteria and provide informed consent.
Participants will be randomly assigned to either the intervention group or the control group. The intervention group will receive a structured education program based on Social Cognitive Theory, delivered in three weekly face-to-face sessions, each lasting approximately 30 minutes. The content of the program includes health promotion, healthy nutrition, physical activity, chronic disease management, self-efficacy enhancement, and health literacy improvement. The control group will receive routine primary care services without additional intervention.
Data will be collected at two time points: baseline (pre-test) and 4-6 weeks after the completion of the intervention (post-test). Outcome measures include self-efficacy, assessed using the General Self-Efficacy Scale; healthy lifestyle behaviors, assessed using the Health-Promoting Lifestyle Profile; and health literacy, assessed using the Health Literacy Scale (short form).
The study is expected to provide evidence on the effectiveness of theory-based educational interventions in promoting health behaviors and improving health literacy among older adults in primary care settings.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Van
-
Van, Van, Tyrkia (Türkiye), 65100
- Tuşba Bardakçı Family Health Center
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Aged 65 years and older
- Able to communicate in Turkish
- Willing to participate and provide informed consent
- Having sufficient cognitive ability to follow the education program
Exclusion Criteria:
- Severe cognitive impairment
- Severe psychiatric disorder
- Acute or life-threatening medical condition
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Intervention Group
Participants in this group will receive a structured Social Cognitive Theory-based education program consisting of three weekly face-to-face sessions, in addition to routine primary care services.
|
A structured face-to-face education program based on Social Cognitive Theory, delivered in three weekly sessions covering health promotion, nutrition, physical activity, self-efficacy, and health literacy.
|
|
Ingen inngripen: Arm Type: Control Group (No Intervention)
Participants in this group will receive routine primary care services without any additional educational intervention.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Self-Efficacy Level
Tidsramme: Baseline and 4-6 weeks after intervention
|
Self-efficacy will be assessed using the General Self-Efficacy Scale (GSES).
The scale consists of 10 items scored on a 4-point Likert scale (1-4), with a total score ranging from 10 to 40.
Higher scores indicate higher levels of self-efficacy (better outcome).
|
Baseline and 4-6 weeks after intervention
|
|
Healthy Lifestyle Behaviors
Tidsramme: Baseline and 4-6 weeks after intervention
|
Healthy lifestyle behaviors will be measured using the Health-Promoting Lifestyle Profile II (HPLP-II).
The scale includes 52 items rated on a 4-point Likert scale (1-4), with total scores ranging from 52 to 208.
Higher scores indicate more positive health-promoting lifestyle behaviors (better outcome).
|
Baseline and 4-6 weeks after intervention
|
|
Health Literacy Level
Tidsramme: Baseline and 4-6 weeks after intervention
|
Health literacy will be assessed using the Health Literacy Scale-Short Form (HLS-SF).
The scale consists of items rated on a Likert-type scale, with total scores ranging from 0 to 50.
Higher scores indicate higher health literacy levels (better outcome).
|
Baseline and 4-6 weeks after intervention
|
Samarbeidspartnere og etterforskere
Sponsor
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Nutbeam D. Health literacy as a public health goal: 25 years on. Health Promot Int. 2025 Jul 1;40(4):daaf119. doi: 10.1093/heapro/daaf119. No abstract available.
- Sorensen K, Pelikan JM, Rothlin F, Ganahl K, Slonska Z, Doyle G, Fullam J, Kondilis B, Agrafiotis D, Uiters E, Falcon M, Mensing M, Tchamov K, van den Broucke S, Brand H; HLS-EU Consortium. Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU). Eur J Public Health. 2015 Dec;25(6):1053-8. doi: 10.1093/eurpub/ckv043. Epub 2015 Apr 5.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2026-228384
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .